英語論文

1. Sato Y, Nakagawa Y, Miki H, Suzuki H, Takahashi M. Cardiac angiosarcoma with ruptured right atrium diagnosed by echocardiography. Chest 1991;100:274-5.
2. Sato Y, Matsumori A. Treatment of coxsackievirus B3 myocarditis by immunoactive peptide in an animal model. Clin Immunol Immunopathol 1992;65:65-9.
3. Kyu B, Matsumori A, Sato Y, Okada I, Chapman NM, Tracy S. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy. Circulation 1992;86:522-30.
4. Sato Y, Maruyama S, Kawai C, Matsumori A. Effect of immunostimulant therapy on acute viral myocarditis in an animal mod
5. Sato Y, Nakagawa Y, Miki H, Suzuki H, Takahashi M. Cardiac angiosarcoma with ruptured right atrium diagnosed by echocardiography. Chest 1991;100:274-5.
6. Sato Y, Matsumori A. Treatment of coxsackievirus B3 myocarditis by immunoactive peptide in an animal model. Clin Immunol Immunopathol 1992;65:65-9.
7. Kyu B, Matsumori A, Sato Y, Okada I, Chapman NM, Tracy S. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy. Circulation 1992;86:522-30.
8. Sato Y, Maruyama S, Kawai C, Matsumori A. Effect of immunostimulant therapy on acute viral myocarditis in an animal model. Am Heart J 1992;124:428-34.
9. Sato Y, Matsumori A, Sasayama S. Autoantibodies against vimentin in a murine model of myocarditis. Autoimmunity 1994;18:145-8.
10. Hirozane T, Matsumori A, Furukawa Y, Matsui S, Sato Y, Matoba Y, Sasayama S. Beneficial effect of amrinone on murine cardiac allograft survival. Clin Exp Immunol 1995;102:186-91.
11. Sato Y, Matsumori A, Sasayama S. Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbilical vein endothelial cells. J Mol Cell Cardiol 1995;27:2265-73.
12. Koshiyama H, Sellitti DF, Akamizu T, Doi SQ, Takeuchi Y, Inoue D, Sakaguchi H, Takemura G, Sato Y, Takatsu Y, Nakao K. Cardiomyopathy associated with Graves' disease. Clin Endocrinol (Oxf) 1996;45:111-6.
13. Matsumori A, Ono K, Sato Y, Shioi T, Nose Y, Sasayama S. Differential modulation of cytokine production by drugs : implications for therapy in heart failure. J Mol Cell Cardiol 1996;28:2491-9.
14. Sasayama S, Matsumori A, Matoba Y, Matsui S, Yamada T, Shioi T, Sato Y, Doyama K, Kishimoto C. Immunomodulation: a new horizon for medical treatment of heart failure. J Card Fail 1996;2(4 Suppl):S287-94. Review.
15. Furukawa Y, Matsumori A, Hirozane T, Matsui S, Sato Y, Ono K, Sasayama S. Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitro. Clin Immunol Immunopathol 1996;79:25-35.
16. Sato Y, Takatsu Y, Ito H, Kataoka K, Takeuchi Y, Matsumori A. Elevated circulating levels of tumor necrosis factor in patients with mitral valve disease and ventricular septum defect. Heart Vessels 1996;11:218-20.
17. Sato Y, Kataoka K, Matsumori A, Sasayama S, Yamada T, Ito H, Takatsu Y. Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy. Heart 1997;78:505-8.
18. Wang WZ, Matsumori A, Yamada T, Shioi T, Okada I, Matsui S, Sato Y, Suzuki H, Shiota K, Sasayama S. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production. Circulation 1997;95:245-51.
19. Sato Y, Yamada T, Taniguchi R, Kataoka K, Sasayama S, Matsumori A, Takatsu Y. Serum concentration of cardiac troponin T in patients with cardiomyopathy: a possible mechanism of acute heart failure. Heart 1998;80:209-10.
20. Matsumori A, Ono K, Okada M, Miyamoto T, Sato Y, Sasayama S. Immediate increase in circulating hepatocyte growth factor/scatter factor by heparin. J Mol Cell Cardiol 1998;30:2145-9.
21. Wang WZ, Matsumori A, Matoba Y, Matsui S, Sato Y, Hirozane T, Shioi T, Sasayama S. Protective effects of Mu-Fang-Ji-Tang against myocardial injury in a murine model of congestive heart failure induced by viral myocarditis. Life Sci 1998;62:1139-46.
22. Taniguchi R, Koshiyama H, Yamauchi M, Tanaka S, Inoue D, Sato Y, Sugawa A, Muramatsu Y, Sasano H. A case of aldosterone-producing adenoma with severe postoperative hyperkalemia. Tohoku J Exp Med 1998;186:215-23.
23. Sato Y, Takatsu Y, Kataoka K, Yamada T, Taniguchi R, Sasayama S, Matsumori A. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol 1999;22:811-3.
24. Sato Y, Taniguchi R, Yamada T, Nagai K, Makiyama T, Okada H, Matsumori A, Sasayama S, Takatsu Y. Measurement of serum concentrations of cardiac troponin T in patients with hypereosinophilic syndrome: a sensitive non-invasive marker of cardiac disorder. Intern Med 2000;39:350.
25. Sato Y, Takatsu Y, Yamada T, Kataoka K, Taniguchi R, Mimura R, Sasayama S, Matsumori A. Interferon treatment for dilated cardiomyopathy and striated myopathy associated with hepatitis C virus infection based on serial measurements of serum concentrations of cardiac troponin T. Jpn Circ J 2000;64:321-4.
26. Sato Y, Yamada T, Taniguchi R, Nagai K, Makiyama T, Okada H, Kataoka K, Ito H, Matsumori A, Sasayama S, Takatsu Y. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001;103: 369-374.
27. Matsumori A, Furukawa Y, Hasegawa K, Sato Y, Nakagawa H, Morikawa Y, Miura K, Ohno Y, Tamakoshi A, Inaba Y, Sasayama S. Epidemiologic and clinical characteristics of cardiomyopathies in Japan: results from nationwide surveys. Circ J 2002;66:323-36.
28. Sato Y, Taniguchi R, Makiyama T, Nagai K, Okada H, Yamada T, Matsumori A, Takatsu Y. Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decompensation. Heart (Scientific letter) 2002; 88: 647 -648.
29. Sato Y, Taniguchi R, Nagai K, Makiyama T, Okada H, Yamada T, Matsumori A, Takatsu Y. Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. Heart (Scientific letter) 2003;89:659-60.
30. Sato Y, Yamada T, Matsumori A. Hepatitis C virus and cardiomyopathy. Cardiomyopathies and heart failure. Biomolecular, infectious and immune mechanisms (Review). P325-339. Edited by Akira Matsumori. Kluwer Academic Publishers. 2003.
31. Sato Y, Kita T, Takatsu Y, Kimura T. Biochemical markers of myocyte injury in heart failure (Review). Heart 2004;90:1110-1113.
32. Taniguchi R, Sato Y, Yamada T, Ooba M, Higuchi H, Matsumori A, Kita T, Kimura T. Combined Measurements of Cardiac Troponin T and N-terminal pro-Brain Natriuretic Peptide in patients with chronic heart failure. Circ J 2004;68:1160-1164.
33. Kato T, Sato Y, Nagao K, Horie T, Kataoka K, Miyamoto T, Takatsu Y. Serum cardiac troponin T in cardiac amyloidosis: Serial observations in five patients. Tohoku J Exp Med 2006;2018:163-167.
34. Taniguchi R, Sato Y, Nishio Y, Kimura T, Kita T. Measurements of baseline and follow up concentrations of cardiac troponin T and brain natriuretic peptide in patients with heart failure from various etiologies. Heart Vessels 2006;21:344-349.
35. Sato Y, Miyamoto T, Taniguchi R, Nishio Y, Kita T, Takatsu Y. Current understanding of biochemical markers in heart failure (Review). Med Sci Monit 2006;12:RA252-264.
36. Tamura T, Furukawa Y, Taniguchi R, Sato Y, Ono K, Horiuchi H, Nakagawa Y, Kita T, Kimura T. Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ J 2007;71:623-630.
37. Nisio Y, Sato Y, Taniguchi R, Shizuta S, Doi T, Morimoto T, Kimura T, Kita T. Cardiac troponin T versus other prognostic biochemical markers in patients with congestive heart failure. Circ J 2007;71:631-635.
38. Kuwabara Y, Sato Y, Miyamoto T, Taniguchi R, et al. Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes. Circ J 2007;71:1047-1051.
39. Sato Y, Kuwabara Y, Taniguchi R, et al. Malignant link between chronic heart failure and acute cardiac decompensation in patients with persistently increased serum concentrations of cardiac troponin (Review). Int J Cardiol 2008;126:171-176.
40. Sato Y, Miyamoto T, Taniguchi R, Nagao K, Matsuoka T, Fukuhara Y, Isoda K, Yamane K, Nishi K, Saijyo S, Fujiwara H, Takatsu Y. The clinical and hemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST. J Cardiol 2009;53:20-27.
41. Sato Y, Nishi K, Taniguchi R, Miyamoto T, Fukuhara R, Yamane K, Saijyo S, Tanada Y, Yamamoto E, Goto T, Takahashi N, Fujiwara H, Takatsu Y. In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events. J Cardiol 2009; 54:221-30.
42. Sato Y, Nishi K, Saijo S, Tanada Y, Goto T, Takahashi N, Yamamoto E, Fukuhara R, Miyamoto T, Taniguchi R, Fujiwara H, Takatsu Y. Serial measurements of high sensitive cardiac troponin I in patients with acutely decompensated heart failure treated with carperitide versus nitrates. J Cardiol 2010;56:66-72.
43. Toda K, Sato Y, Hara T, Hijiya K, Kaneko R, Okada T, Takatsu Y, Fujiwara H, Iwasaki T. Correlates of NT-proBNP concentration in patients with essential hypertension in absence of congestive heart failure. J Clin Lab Anal 2010;24:12-6.
44. Yoshitani Y, Sato Y. Prediction of Acute Heart Failure Decompensation (EDITORIAL). Circ J 2011;75:55-56.
45. Sato Y, Yamamoto E, Sawa T, Toda K, Hara T, Iwasaki T, Fujiwara H, Takatsu Y. High-sensitivity cardiac troponin T in essential hypertension. J Cardiol 2011;58:226-231.
46. Sato Y, Fujiwara H, Takatsu Y. Biochemical markers in heart failure. J Cardiol 2012;59:1-7.
47. Nishi K, Sato Y, Miyamoto T, Toma M, Taniguchi R, Fukuhara R, Saijo S, Fujiwara H, Takatsu Y. Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure. J Cardiol 2012;59:366-373.
48. Sato Y, Fujiwara H, Takatsu Y. Cardiac troponin and heart failure in the era of high-sensitivity assays. J Cardiol 2012;60:160-7.
49. Yamamoto E, Sato Y, Sawa T, Fujiwara T, Fujiwara H, Takatsu Y. Correlation between serum concentrations of B-type natriuretic Peptide and albumin in patients with chronic congestive heart failure. Int Heart J 2012;53:234-237.
50. Tanada Y, Sato Y, Sawa T, Fujiwara H, Takatsu Y. Serial measurements of high-sensitivity cardiac troponin I and N-terminal B-type natriuretic peptide in a patient presenting with cardiac sarcoidosis. Intern Med 2012;51:3379-81.
51. Sato Y. Angiotensin II receptor blockers for patients with chronic heart failure: The next step forward. J Cardiol 2013;61:307-8.
52. Sato Y. Diagnostic and prognostic property of NT-proBNP in patients with renal dysfunction. J Cardiol 2013;61:446-7.
53. Koyama S, Sato Y, Tanada Y, Fujiwara H, Takatsu Y. Early Evolution and Correlates of Urine Albumin Excretion in Patients Presenting With Acutely Decompensated Heart Failure. Circ Heart Fail 2013;6:227-232.
54. JointWorking Groups. Guidelines for the Diagnosis and Treatment of Cardiovascular Diseases (2010 Joint Working Groups Report) [Digest Version] Guidelines for Treatment of Acute Heart Failure (JCS 2011). Circ J 2013;77:2157-2201.
55. Sato Y, Minatoguchi S, Nishigaki K, Hirata KI, Masuyama T, Furukawa Y, Uematsu M, Yoshikawa J, Otsuji S, Iida M, Fujiwara H. for the SHYOGI study investigators. Design of prospective study of acute coronary syndrome hospitalization after smoking ban in public places in Hyogo prefecture: Comparison with Gifu, a prefecture without a public smoking ban. J Cardiol 2014;63:165-8.
56. Koyama S, Sato Y, Tanada Y, Fujiwara H, Takatsu Y. Prognostic contribution of urine osmolality in patients presenting with acute heart failure. Int J Cardiol 2014;174:158-159
57. Sawa T, Sato Y, Matsuda M, Tanaka M, Miyazaaki S, Furukawa Y, Kita Y, Takatsu Y, Fujiwara H.Regression of Electrocardiographic Signs of Left Ventricular Hypertrophy by Combined Treatment With Thiazide Diuretic and Angiotensin-Ⅱ Receptor Blocker. –Randomized Multicenter Trial- Circ J 2014;78:2719-2726
58. Shionimya H, Koyama S, Tanada Y, Takahashi N, Fujiwara H, Takatsu Y, Sato Y.　 Left ventricular end-diastolic pressure and ejection fraction correlate independently with high-sensitivity cardiac troponin-T concentrations in stable heart failure.　J Cardiol. 2015;65:526-30.
59. Yoshitani K, Miyamoto T, Sato Y, Takatsu Y. Another gate keeper to protect the mitral isthmus? Importance of the vein of Marshall. J Cardiovasc Electrophysiol 2015;26:352-3.
60. Sato Y. Multidisciplinary management of heart failure just beginning in Japan. J Cardiol. 2015;66:181-8
61. Sato Y. Renin- A Historical Biomarker of Heart Failure. Circ J 2015;79:1206-12018
62. Kujira K, Yoshitani K, Futsuki A, Imai K, Hiraumi Y, Sakazaki H, Sato Y, Takatsu Y, Toyohara K, Fujiwara K Ventricular Tachycardia Rotating a Scar of a Total Right Ventricular Exclusion. Ann Thorac Surg 2015;100:1886-8.
63. Inazumi H, Koyama S, Tanada Y, Fujiwara H, Takatsu Y, Sato Y. Prognostic significance of changes in cystatin C during treatment of acute cardiac decompensation. J Cardiol 2016;67:98-103.
64. Nakayama H, Koyama S, Kuragaichi T, Shiba M, Fujiwara H, Takatsu Y, Sato Y. Prognostic Value of Rising Serum Albumin During Hospitalization in Patients With Acute Heart Failure. Am J Cardiol 2016;117:1305-9.
65. Sato Y, Minatoguchi S, Nishigaki K, Hirata KI, Masuyama T, Furukawa Y, Uematsu M, Yoshikawa J, Otsuji S, Iida M, Fujiwara H; SHYOGI Study Investigators..　 Results of a Prospective Study of Acute Coronary Syndrome Hospitalization After Enactment of a Smoking Ban in Public Places in Hyogo Prefecture　- Comparison With Gifu, a Prefecture Without a Public Smoking Ban. Circ J. 2016;80:2528-2532.
66. Yamamoto E, Kato T, Ozasa N, Yaku H, Inuzuka Y, Tamaki Y, Kitai T, Morimoto T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawashima T, Motohashi Y, Kawato M, Toyofuku M, Sato Y, Kuwahara K, Shioi T, Kimura T; KCHF study investigators. Kyoto Congestive Heart Failure (KCHF) study: rationale and design. ESC Heart Fail 2017;4:216-223.
67. Koyama S, Kuragaichi T, Sato Y, Kuwabara Y, Usami S, Horie T, Baba O, Hakuno D, Nakashima Y, Nishino T, Nishiga M, Nakao T, Arai H, Kimura T, Ono K. Dynamic changes of serum microRNA-122-5p through therapeutic courses indicates amelioration of acute liver injury accompanied by acute cardiac decompensation. ESC Heart Fail 2017;4:112-121.
68. Nagao K, Tamura A, Morimoto T, Shimamura K, Yukawa H, Ito H, Hayashi F, Makita T, Takemura G, Sato Y, Inada T, Kimura T, Tanaka M Liver fibrogenesis marker, 7S domain of collagen type IV in patients with acutely decompensated heart failure: Correlates, prognostic value and time course. Int J Cardiol 2017;236:483-487.
69. Kurozumi Y, Oishi S, Sugano Y, Sakashita A, Kotooka N, Suzuki M, Higo T, Yumino D, Takada Y, Maeda S, Yamabe S, Washida K, Takahashi T, Ohtani T, Sakata Y, Sato Y. Design of a nationwide survey on palliative care for end-stage heart failure in Japan. J Cardiol 2018;71:202-211.
70. Yaku H, Ozasa N, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Sasaki K, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kato T, Kimura T; KCHF Study Investigators. Demographics, Management, and In-Hospital Outcome of Hospitalized Acute Heart Failure Syndrome Patients in Contemporary Real Clinical Practice in Japan　- Observations From the Prospective, Multicenter Kyoto Congestive Heart Failure (KCHF) Registry. Circ J 2018;82:2811-2819.
71. Shimizu Y, Yoshitani K, Murotani K, Kujira K, Kurozumi Y, Fukuhara R, Taniguchi R, Toma M, Miyamoto T, Kita Y, Takatsu Y, Sato Y. The deeper the pouch is, the longer the radiofrequency duration and higher the radiofrequency energy needed-Cavotricuspid isthmus ablation using intracardiac echocardiography. J Arrhythm 2018;34:410-417.
72. Tsuji S, Koyama S, Taniguchi R, Fujiwara T, Fujiwara H, Sato Y. Nutritional status of outpatients with chronic stable heart failure based on serum amino acid concentration. J Cardiol 2018;72:458-465.
73. Kuragaichi T, Kurozumi Y, Ohishi S, Sugano Y, Sakashita A, Kotooka N, Suzuki M, Higo T, Yumino D, Takada Y, Maeda S, Yamabe S, Washida K, Takahashi T, Ohtani T, Sakata Y, Sato Y. Nationwide Survey of Palliative Care for Patients With Heart Failure in Japan. Circ J 2018;82:1336-1343.
74. Sato Y, Kita Y, Shimada M, Matsushita K, Fujiwara H. Survey on the Status of Smoking Inside Eating Establishments in the Cities of Kobe and Amagasaki. Circ J 2018;82:1852-1857.
75. Tsuji S, Koyama S, Taniguchi R, Fujiwara T, Fujiwara H, MD, Sato Y. Association of Serum Amino Acid Concentration WithLoss of Skeletal Muscle Mass After 1 Year in Cardiac Rehabilitation Center Patients. Circ Rep 2019; 1: 456 – 461.
76. Su K, Kato T, Toyofuku M, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Motohashi Y, Watanabe H, Kitai T, Taniguchi R, Iguchi M, Kato M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Jinnai T, Kawato M, Sato Y, Kuwahara K, Tamura T, Kimura T, KCHF Registry Investigators. Association of Previous Hospitalization for Heart Failure With Increased Mortality in Patients Hospitalized for Acute Decompensated Heart Failure. Circ Rep 2019: 1:517-524.
77. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T. Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry. J Thromb Thrombolysis 2019;48:587-595.
78. Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Seko Y, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T. Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart Failure. JAMA Netw Open 2019 Jun 5;2(6):e195892. doi: 10.1001/jamanetworkopen.2019.5892.
79. Kamiya K, Yamamoto T, Tsuchihashi-Makaya M, Ikegame T, Takahashi T, Sato Y, Kotooka N, Saito Y, Tsutsui H, Miyata H, Isobe M. Nationwide Survey of Multidisciplinary Care and Cardiac Rehabilitation for Patients With Heart Failure in Japan　- An Analysis of the AMED-CHF Study. Circ J 2019;83:1546-1552.
80. Kuragaichi T, Kataoka Y, Miyakoshi C, Miyamoto T, Sato Y. External validation of pooled cohort equations using systolic blood pressure intervention trial data. BMC Res Notes 2019;12:271.
81. Nishimoto Y, Fukuhara R, Toma M, Taniguchi R, Miyamoto T, Sato Y. Vascular responses to a Viabahn stent graft: evaluation with computed tomographic angiography, angiography, and angioscopy. Cardiovasc Interv Ther 2019;34:390-392.
82. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T. Clinical Characteristics and Outcomes of Venous Thromboembolisms According to an Out-of-Hospital vs. In-Hospital Onset　- From the COMMAND VTE Registry. Circ J 2019;83:1377-1384.
83. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T. Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry. Heart Vessels 2019;34:669-677.
84. Kurozumi Y, Oishi S, Sugano Y, Sakashita A, Kotooka N, Suzuki M, Higo T, Yumino D, Takada Y, Maeda S, Yamabe S, Washida K, Takahashi T, Ohtani T, Sakata Y, Sato Y. Possible associations between palliative care conferences and positive outcomes when performing palliative care for patients with end-stage heart failure: a nationwide cross-sectional questionnaire survey. Heart Vessels 2019;34:452-461.
85. Nakayama H, Toma M, Kobayashi T, Ohno N, Okada T, Ueno G, Sato Y. Ruptured Abdominal Aortic Aneurysm Treated by Double-Balloon Technique and Endovascular Strategy: Case Series. Ann Thorac Cardiovasc Surg 2019;25:211-214.
86. Nishimoto Y, Fukuhara R, Miyamoto T, Toma M, Miyata A, Sato Y. Edge restenosis of a polytetrafluoroethylene-covered stent in the superficial femoral artery: insights from an imaging assessment with an electronic high-resolution angioscope. Cardiovsc Interv Ther 2020;35:98-100.
87. Nishimoto Y, Fukuhara R, Otsuka F, Toma M, Miyamoto T, Sato Y. A superficial femoral artery calcification: insights from a multi-imaging modality assessment with computed tomography, electronic high-resolution angioscopy, and optical frequency domain imaging. Cardiovasc Interv Ther 2020;35:313-314.
88. Ikeda S, Fukuhara R, Nishimoto Y, Taniguchi R, Sato Y. A percutaneous intravascular cracking (PICKING) with a TruePath™ for extremely calcified lesions. Cardiovsc Interv Ther 2020;35:310-12.
89. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Group. Validation of the VTE-BLEED score's long-term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry. J Thromb Haemost. 2020;18:624-632.
90. Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Kato M, Ikeda T, Furukawa Y, Nakagawa Y, Sato Y, Kuwahara K, Kimura T. Risk factors and clinical outcomes of functional decline during hospitalization in very old patients with acute decompensated heart failure: an observational study. BMJ Open 2020;10:e032674.
91. Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Ozasa N, Kimura T. Association with Controlling Nutritional Status (CONUT) Score and In-hospital Mortality and Infection in Acute Heart Failure. Sci Rep 2020 Feb 24;10(1):3320. doi: 10.1038/s41598-020-60404-9.
92. Nagao K, Tamura A, Sato Y, Hata R, Kawase Y, Kadota K, Horie T, Sowa N, Nishiga M, Ono K, Inada T, Tanaka M. Utility of collagen-derived peptides as markers of organ injury in patients with acute heart failure. Open Heart 2020 Apr 5;7(1):e001041. doi: 10.1136/openhrt-2019-001041. eCollection 2020.
93. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Investigators. Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE Registry. Thromb Res 2020;191:66-75.
94. Miyagawa S, Miyamoto T, Sato Y. Soluble Tumour Necrosis Factor-Alpha Receptor Improved the Function, Hypertrophy, and Granular Sparkling Appearance of the Left Ventricular Myocardium in Systemic Amyloid A Amyloidosis: A Case Report. Eur Heart J Case Rep. 2020;4:1-7.
95. Yamamoto K, Tsuchihashi-Makaya M, Kinugasa Y, Iida Y, Kamiya K, Kihara Y, Kono Y, Sato Y, Suzuki N, Takeuchi H, Higo T, Miyazawa Y, Miyajima I, Yamashina A, Yoshita K, Washida K, Kuzuya M, Takahashi T, Nakaya Y, Hasebe N, Tsutsui H; Japanese Heart Failure Society, Expert Consensus Writing Committee. Japanese Heart Failure Society 2018 Scientific Statement on Nutritional Assessment and Management in Heart Failure Patients. Circ J. 2020;84:1408-1444.
96. Yamamoto E, Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Himura Y, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Seko Y, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. Sex differences in patients with acute decompensated heart failure in Japan: observation from the KCHF registry. ESC Heart Fail. 2020;5:2485-2493.
97. Yoshikawa Y, Tamaki Y, Morimoto T, Yaku H, Yamamoto E, Inuzuka Y, Ozasa N, Kitai T, Nagao K, Sato Y, Kondo H, Tamura T, Nakagawa Y, Kuwahara K, Kato T, Kimura T. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry. PLoS One doi: 10.1371/journal.pone.0239100. eCollection 2020.
98. Kamiya K, Sato Y, Takahashi T, Tsuchihashi-Makaya M, Kotooka N, Ikegame T, Takura T, Yamamoto T, Nagayama M, Goto Y, Makita S, Isobe M. Multidisciplinary Cardiac Rehabilitation and Long-Term Prognosis in Patients With Heart Failure. Circ Heart Fail 2020;13:e006798.
99. Nishimoto Y, Yamashita Y, Kim K, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Investigators. Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism - From the COMMAND VTE Registry. Circ J 2020;84:2006-2014.
100. Seko Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Association between body mass index and prognosis of patients hospitalized with heart failure. Sci Rep. 2020 Oct 7;10(1):16663.
101. Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Seko Y, Shiba M, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study. PLoS One. 2020 Dec 28;15(12):e0243818.
102. Nakayama H, Nishimoto Y, Hotta K, Sato Y. Safety of Early Enteral Nutrition for Cardiac Medical Critically Ill Patients - A Retrospective Observational Study. Circ Rep. 2020 Sep 8;2(10):560-564.
103. Nishimoto Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Kuwahara K, Ozasa N, Sato Y, Kimura T. C-reactive protein at discharge and 1-year mortality in hospitalised patients with acute decompensated heart failure: an observational study. BMJ Open 2020 Dec 29;10(12):e041068.
104. Nishimoto Y, Toma M, Matsui Y, Fukuhara R, Miyamoto T, Sato Y. Successful Fogarty venous thrombectomy without a skin incision for organized thrombi caused by May-Thurner syndrome. Cardiovasc Interv Ther 2021;36:549-550.
105. Ikeda S, Imai M, Yoshizawa K, Miyamoto T, Fujiwara K, Sato Y. Cardiac erosion causing an aortic dissection after a catheter closure of an atrial septal defect: first late erosion case with the Figulla Flex II septal occluder. Cardiovasc Interv Ther 2021;36:270-272.
106. Hata R, Kato T, Yaku H, Morimoto T, Kawase Y, Yamamoto E, Inuzuka Y, Tamaki Y, Ozasa N, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Morinaga T, Furukawa Y, Kadota K, Sato Y, Kimura T. Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry. J Cardiol 2021;77:292-299.
107. Natsuaki M, Morimoto T, Shiomi H, Ehara N, Taniguchi R, Tamura T, Tada T, Suwa S, Kaneda K, Watanabe H, Tazaki J, Watanabe S, Yamamoto E, Saito N, Fuki M, Takeda T, Eizawa H, Shinoda E, Mabuchi H, Shirotani M, Uegaito T, Matsuda M, Takahashi M, Inoko M, Tamura T, Ishii K, Onodera T, Sakamoto H, Aoyama T, Sato Y, Ando K, Furukawa Y, Nakagawa Y, Kadota K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators.　Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-3. Circ J 2021;85:769-781.
108. Kuragaichi T, Sato Y. Temporal trends of a vasopressin V 2 receptor antagonist in heart failure using a nationwide database in Japan. ESC Heart Fail 2021;8:527-538.
109. Yamamoto K, Shiomi H, Morimoto T, Kadota K, Tada T, Takeji Y, Matsumura-Nakano Y, Yoshikawa Y, Imada K, Domei T, Kaneda K, Taniguchi R, Ehara N, Nawada R, Natsuaki M, Yamaji K, Toyofuku M, Kanemitsu N, Shinoda E, Suwa S, Iwakura A, Tamura T, Soga Y, Inada T, Matsuda M, Koyama T, Aoyama T, Sato Y, Furukawa Y, Ando K, Yamazaki F, Komiya T, Minatoya K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 investigators. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3). Am J Cardiol. 2021;145:47-57.
110. Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Takeji Y, Kadota K, Imada K, Toyofuku M, Kanemitsu N, Shinoda E, Suwa S, Iwakura A, Tamura T, Soga Y, Inada T, Matsuda M, Koyama T, Aoyama T, Kato E, Sato Y, Furukawa Y, Ando K, Yamazaki F, Komiya T, Minatoya K, Nakagawa Y, Kimura T. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With versus Without Chronic Kidney Disease. Am J Cardiol. 2021;145:37-46.
111. Tsujimoto H, Kataoka Y, Sato Y, Banno M, Tsujino-Tsujimoto E, Sumi Y, Sada R, Fujiwara T, Ohtake Y, Kumasawa J, Imura H, Matsuda Y, So R, Kagawa T, Yoshioka T, Uneno Y, Nagano H, Akazawa M, Hozumi T, Tsujimoto Y. A model six-month workshop for developing systematic review protocols at teaching hospitals: action research and scholarly productivity. BMC Med Educ. 2021 Feb 10;21(1):98. doi: 10.1186/s12909-021-02538-6.
112. Takeji Y, Shiomi H, Morimoto T, Yoshikawa Y, Taniguchi R, Mutsumura-Nakano Y, Yamamoto K, Yamaji K, Tazaki J, Suwa S, Inoko M, Takeda T, Shirotani M, Ehara N, Ishii K, Inada T, Onodera T, Shinoda E, Yamamoto T, Tamura T, Nakatsuma K, Sakamoto H, Ando K, Soga Y, Furukawa Y, Sato Y, Nakagawa Y, Kadota K, Komiya T, Minatoya K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 and the CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3. BMJ Open. 2021 Feb 22;11(2):e044329. doi: 10.1136/bmjopen-2020-044329.
113. Shiba M, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. Prognostic value of reduction in left atrial size during a follow-up of heart failure: an observational study. BMJ Open. 2021 Feb 19;11(2):e044409. doi: 10.1136/bmjopen-2020-044409.
114. Shiba M, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Serum cholinesterase as a prognostic biomarker for acute heart failure. Eur Heart J Acute Cardiovasc Care. 2021;10:335-342.
115. Nishimoto Y, Toma M, Miyamoto R, Miyata A, Sato Y. Successful Percutaneous Fogarty Arterial Thrombectomy for Acute Lower Limb Ischemia. JACC Cardiovasc Interv. 2021;14:706-708.
116. Sugiyama T, Kataoka Y, Shindo K, Hino M, Itoi K, Sato Y, Tanaka S. Retrolaminar Block Versus Paravertebral Block for Pain Relief After Less-Invasive Lung Surgery: A Randomized, Non-Inferiority Controlled Trial. Cureus. 2021 Feb 27;13(2):e13597.
117. Takeji Y, Shiomi H, Morimoto T, Yoshikawa Y, Taniguchi R, Mutsumura-Nakano Y, Yamamoto K, Yamaji K, Tazaki J, Kato ET, Watanabe H, Yamamoto E, Yamashita Y, Fuki M, Suwa S, Inoko M, Takeda T, Shirotani M, Ehara N, Ishii K, Inada T, Tamura T, Onodera T, Shinoda E, Yamamoto T, Watanabe H, Yaku H, Nakatsuma K, Sakamoto H, Ando K, Soga Y, Furukawa Y, Sato Y, Nakagawa Y, Kadota K, Komiya T, Minatoya K, Kimura T; CREDO-Kyoto AMI Registry Wave-1 and the CREDO-Kyoto AMI Registry Wave-2 Investigators. Changes in demographics, clinical practices and long-term outcomes of patients with ST segment-elevation myocardial infarction who underwent coronary revascularisation in the past two decades: cohort study. BMJ Open. 2021 Mar 31;11(3):e043683.
118. Natsuaki M, Morimoto T, Shiomi H, Kadota K, Tada T, Takeji Y, Matsumura-Nakano Y, Yoshikawa Y, Watanabe H, Yamamoto K, Imada K, Domei T, Yamaji K, Kaneda K, Taniguchi R, Ehara N, Nawada R, Toyofuku M, Shinoda E, Suwa S, Tamura T, Inada T, Matsuda M, Aoyama T, Sato Y, Furukawa Y, Ando K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary Intervention. Circ J. 2021 Oct 25;85(11):1928-1941.
119. Seko Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. A decrease in tricuspid regurgitation pressure gradient associates with favorable outcome in patients with heart failure. ESC Heart Fail. 2021 Aug;8(4):2826-2836.
120. Nishimoto Y, Yamashita Y, Morimoto T, Sato Y, Kimura T; COMMAND VTE Registry Investigators. Risk factors of recurrence in patients with cancer-associated venous thromboembolism. Eur J Intern Med. 2021;91:98-101.
121. Tamaki Y, Yaku H, Morimoto T, Inuzuka Y, Ozasa N, Yamamoto E, Yoshikawa Y, Miyake M, Kondo H, Tamura T, Kitai T, Iguchi M, Nagao K, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Toyofuku M, Sato Y, Kuwahara K, Nakagawa Y, Kato T, Kimura T; KCHF Study Investigators. Lower In-Hospital Mortality With Beta-Blocker Use at Admission in Patients With Acute Decompensated Heart Failure. J Am Heart Assoc. 2021 Jul 6;10(13):e020012.
122. Kawase Y, Kato T, Morimoto T, Hata R, Murai R, Tada T, Katoh H, Kadota K, Yamamoto E, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Yoshikawa Y, Iguchi M, Nagao K, Sato Y, Kuwahara K, Kimura T. Admission systolic blood pressure as a prognostic predictor of acute decompensated heart failure: A report from the KCHF registry. PLoS One. 2021 Jul 2;16(7):e0253999.
123. Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yoshikawa Y, Yamaji K, Tada T, Tazaki J, Ehara N, Taniguchi R, Tamura T, Iwakura A, Tada T, Watanabe H, Suwa S, Toyofuku M, Inada T, Kaneda K, Ogawa T, Takeda T, Sakai H, Yamamoto T, Tambara K, Esaki J, Eizawa H, Yamada M, Shinoda E, Nishizawa J, Mabuchi H, Tamura N, Shirotani M, Nakayama S, Uegaito T, Matsuda M, Takahashi M, Inoko M, Kanemitsu N, Tamura T, Ishii K, Nawada R, Onodera T, Ohno N, Koyama T, Tsuneyoshi H, Sakamoto H, Aoyama T, Miki S, Tanaka M, Sato Y, Yamazaki F, Hanyu M, Soga Y, Komiya T, Ando K, Minatoya K, Kimura T. Coronary Revascularization in the Past Two Decades in Japan (From the CREDO-Kyoto PCI/CABG Registries Cohort-1, -2, and -3). Am J Cardiol 2021;153:20-29.
124. Murai R, Kawase Y, Taniguchi T, Morimoto T, Kadota K, Ohya M, Shimada T, Maruo T, Fuku Y, Komiya T, Ando K, Hanyu M, Kanamori N, Aoyama T, Murata K, Onodera T, Yamazaki F, Kitai T, Furukawa Y, Koyama T, Miyake M, Izumi C, Nakagawa Y, Yamanaka K, Mitsuoka H, Shirotani M, Kato M, Miki S, Nakajima H, Hirano Y, Miyazaki S, Saga T, Sugioka S, Matsuda S, Matsuda M, Ogawa T, Nagao K, Inada T, Nakayama S, Mabuchi H, Takeuchi Y, Sakamoto H, Sakaguchi G, Yamane K, Eizawa H, Toyofuku M, Tamura T, Iwakura A, Ishii M, Akao M, Shiraga K, Minamino-Muta E, Kato T, Inoko M, Ueyama K, Ikeda T, Himura Y, Komasa A, Ishii K, Hotta K, Sato Y, Fujiwara K, Kato Y, Kouchi I, Inuzuka Y, Ikeguchi S, Miwa S, Maeda C, Shinoda E, Nishizawa J, Jinnai T, Higashitani N, Kitano M, Morikami Y, Kitaguchi S, Minatoya K, Kimura T; CURRENT AS Registry Investigators. Concomitant Mitral Regurgitation in Severe Aortic Stenosis - A Report From the CURRENT AS Registry. Circ J. 2022;86:427-437.
125. Yamamoto K, Matsumura-Nakano Y, Shiomi H, Natsuaki M, Morimoto T, Kadota K, Tada T, Takeji Y, Yoshikawa Y, Imada K, Domei T, Kaneda K, Taniguchi R, Ehara N, Nawada R, Yamaji K, Kato E, Toyofuku M, Kanemitsu N, Shinoda E, Suwa S, Iwakura A, Tamura T, Soga Y, Inada T, Matsuda M, Koyama T, Aoyama T, Sato Y, Furukawa Y, Ando K, Yamazaki F, Komiya T, Minatoya K, Nakagawa Y, Kimura T; CREDO‐Kyoto PCI/CABG Registry Cohort‐3 Investigators. Effect of Heart Failure on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery Disease. J Am Heart Assoc. 2021 Aug 3;10(15):e021257.
126. Washida K, Kato T, Ozasa N, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Risk Factors and Clinical Outcomes of Nonhome Discharge in Patients With Acute Decompensated Heart Failure: An Observational Study. J Am Heart Assoc. 2021 Aug 3;10(15):e020292.
127. Seko Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. Improved and new-onset anemia during follow-up in patients with acute decompensated heart failure: Characteristics and outcomes. Medicine (Baltimore). 2021 Aug 13;100(32):e26892.
128. Nishimoto Y, Toma M, Iwasa K, Sato Y. Successful staged management of a spontaneous iliac vein rupture associated with May-Thurner syndrome: a case report. Eur Heart J Case Rep. 2021 Aug 4;5(8):ytab316.
129. Natsuaki M, Morimoto T, Shiomi H, Yamamoto K, Yamaji K, Watanabe H, Uegaito T, Matsuda M, Tamura T, Taniguchi R, Inoko M, Mabuchi H, Takeda T, Domei T, Shirotani M, Ehara N, Eizawa H, Ishii K, Tanaka M, Inada T, Onodera T, Nawada R, Shinoda E, Yamada M, Yamamoto T, Sakai H, Toyofuku M, Tamura T, Takahashi M, Tada T, Sakamoto H, Tada T, Kaneda K, Miki S, Aoyama T, Suwa S, Sato Y, Ando K, Furukawa Y, Nakagawa Y, Kadota K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-Investigators. Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan - From the CREDO-Kyoto Registry Cohort-2 and Cohort-3. Circ J. 2021 Sep 16. doi: 10.1253/circj.CJ-21-0526.
130. Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Yamamoto K, Takeji Y, Tada T, Nagao K, Yamaji K, Kaneda K, Suwa S, Tamura T, Sakamoto H, Inada T, Matsuda M, Sato Y, Furukawa Y, Ando K, Kadota K, Nakagawa Y, Kimura T; CREDO‐Kyoto AMI Registry Wave‐2 Investigators. Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction. J Am Heart Assoc. 2021 Sep 21;10(18):e021417.
131. Sato Y, Kuragaichi T, Saga S, Nakayama H, Obata T, Watanabe M, Fujikura K, Watanabe M, Hata KI, Ohgushi H. Safety of Intravenous Autologous Bone Marrow-Derived Mesenchymal Cell Transplantation in 5 Patients With Reduced Left Ventricular Ejection Fraction. Circ Rep. 2021 Aug 18;3(9):550-554.
132. Iguchi M, Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Hamatani Y, Yamashita Y, Masunaga N, Ogawa H, Ishii M, An Y, Taniguchi R, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Seko Y, Toyofuku M, Furukawa Y, Ando K, Kadota K, Abe M, Akao M, Sato Y, Kuwahara K, Kimura T. Ischemic Stroke in Acute Decompensated Heart Failure: From the KCHF Registry. J Am Heart Assoc. 2021 Nov 2;10(21):e022525.
133. Seko Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Jinnai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. Newly Diagnosed Infection After Admission for Acute Heart Failure: From the KCHF Registry. J Am Heart Assoc. 2021 Nov 16;10(22):e023256.
134. Takeji Y, Shiomi H, Morimoto T, Yamamoto K, Matsumura-Nakano Y, Nagao K, Taniguchi R, Yamaji K, Tada T, Kato ET, Yoshikawa Y, Obayashi Y, Suwa S, Inoko M, Ehara N, Tamura T, Onodera T, Watanabe H, Toyofuku M, Nakatsuma K, Sakamoto H, Ando K, Furukawa Y, Sato Y, Nakagawa Y, Kadota K, Kimura T; CREDO-Kyoto AMI Registry Wave-2 Investigators. Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarction. PLoS One. 2021 Nov 17;16(11):e0259268.
135. Hotta K, Taniguchi R, Nakayama H, Yamaguchi F, Sato Y. The Effects of an Oral Nutritional Supplement with Whey Peptides and Branched-Chain Amino Acids for Cardiac Rehabilitation of Patients with Chronic Heart Failure. Int Heart J. 2021 Nov 30;62(6):1342-1347.
136. Seko Y, Kishimori T, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. Coronary angiography in patients with acute heart failure: from the KCHF registry. ESC Heart Fail. 2022;9:531-544.
137. Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Takeji Y, Yamaji K, Matsumura-Nakano Y, Yoshikawa Y, Yamamoto E, Fuki M, Kato E, Yamashita Y, Yaku H, Nakatsuma K, Watanabe H, Matsuda M, Tamura T, Inoko M, Mabuchi H, Shirotani M, Eizawa H, Ishii K, Inada T, Onodera T, Shinoda E, Yamamoto T, Toyofuku M, Takahashi M, Sakamoto H, Miki S, Aoyama T, Suwa S, Sato Y, Furukawa Y, Ando K, Kadota K, Nakagawa Y, Kimura T; Credo-Kyoto PCI/CABG Registry Investigators. Coronary Artery Disease Without Standard Cardiovascular Risk Factors. Am J Cardiol. 2022 Feb 1;164:34-43.
138. Nishimoto Y, Fukuhara R, Toma M, Sato Y. A novel technique: passing through bulky calcified nodules projecting into a popliteal artery using a TruePath crossing device: A novel CanPath technique. AsiaIntervention. 2020 Dec;6(2):104-105.
139. Nishimoto Y, Hara R, Taniguchi R, Toma M, Sato Y. Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock. Circ Rep. 2021 Oct 22;3(12):742-743.
140. Ozasa N, Kato T, Morimoto T, Yaku H, Yamamoto E, Inuzuka Y, Tamaki Y, Kitai T, Washida K, Seko Y, Yoshikawa Y, Sato Y, Motoki H, Kuwahara K, Kimura T. Polypharmacy and Clinical Outcomes in Hospitalized Patients With Acute Decompensated Heart Failure. J Cardiovasc Nurs. 2022 Jan 14. doi: 10.1097/JCN.0000000000000885.
141. Nagao K, Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inada T, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Ozasa N, Kimura T. Current use of inotropes according to initial blood pressure and peripheral perfusion in the treatment of congestive heart failure: findings from a multicentre observational study. BMJ Open. 2022 Jan 20;12(1):e053254.
142. Shiba M, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Nakagawa Y, Kuwahara K, Kimura T. Changes in BNP levels from discharge to 6-month visit predict subsequent outcomes in patients with acute heart failure. PLoS One. 2022 Jan 28;17(1):e0263165.
143. Seko Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. Starting Neurohormonal Antagonists in Patients With Acute Heart Failure With Mid-Range and Preserved Ejection Fraction. Circ J. 2022 Sep 22;86(10):1547-1558
144. Nishimoto Y, Ohbe H, Matsui H, Nakajima M, Sasabuchi Y, Goto T, Morita K, Fushimi K, Sato Y, Yasunaga H. Predictive ability of the sequential organ failure assessment score for in-hospital mortality in patients with cardiac critical illnesses: a nationwide observational study. Eur Heart J Acute Cardiovasc Care. 2022 Jun 7;11(4):312-321.
145. Nishimoto Y, Kato T, Morimoto T, Taniguchi R, Yaku H, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Kuwahara K, Ozasa N, Sato Y, Kimura T. Public assistance in patients with acute heart failure: a report from the KCHF registry. ESC Heart Fail. 2022 Jun;9(3):1920-1930.
146. Shiba M, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Left atrial reverse remodeling improves risk stratification in patients with heart failure with recovered ejection fraction. Sci Rep. 2022 Mar 16;12(1):4473.
147. Nishimoto Y, Okayama K, Toma M, Sato Y. Different Positions of the Impella Device Between the Axillary and Femoral Approaches. Circ Rep. 2022 Feb 19;4(4):183-184.
148. Seko Y, Yamamoto E, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. Insomnia in patients with acute heart failure: from the KCHF registry. ESC Heart Fail. 2022 Oct;9(5):2988-2996.
149. Yamamoto E, Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Seko Y, Shiba M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T. Appetite loss at discharge from acute decompensated heart failure: Observation from KCHF registry. PLoS One. 2022 May 5;17(5):e0267327.
150. Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Nishikawa R, Kaneda K, Yamamoto K, Takeji Y, Komasa A, Yamaji K, Shizuta S, Tada T, Nagao K, Suwa S, Tamura T, Sakamoto H, Inada T, Matsuda M, Sato Y, Furukawa Y, Ando K, Kadota K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Stroke Risk Stratification With the CHADS2 Score in Patients Without Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention. Am J Cardiol. 2022 Oct 15;181:9-17.
151. Miyamoto R, Miyamoto T, Nishimoto Y, Nakayama H, Sato Y. Exercise echocardiography for a differential diagnosis in a patient with radiation-induced heart disease: A case report. J Cardiol Cases. 2022 Jul 28;26(5):329-332.
152. Sato Y, Kuragaichi T, Nakayama H, Hotta K, Nishimoto Y, Kato T, Taniguchi R, Washida K.Developing Multidisciplinary Management of Heart Failure in the Super-Aging Society of Japan. Circ J 2022 Dec 23. doi: 10.1253/circj.CJ-22-0675. Online ahead of print.
153. Miyamoto R, Nagao K, Matsuto K, Hata R, Kawase Y, Maruichi-Kawakami S, Aida K, Kadota K, Sato Y, Inada T. Miyamoto R, Nagao K, Matsuto K, Hata R, Kawase Y, Maruichi-Kawakami S, Aida K, Kadota K, Sato Y, Inada T.Int J Cardiol. 2023 Mar 1;374:51-57. Int J Cardiol. 2023 Mar 1;374:51-57.
154. Ikeda S, Nishimoto Y, Toma S, Sato Y. Rupture of Non-aneurysmal Mycotic Thoracic Aortic Arteritis Caused by Campylobacter fetus. Cureus 2023 PMID: 38192951.
155. Matsuda H, Kuragaichi T, Sato Y. Investigating the seasonal variation of heart failure hospitalizations and in-hospital mortality risks in Japan using a nationwide database. J Cardiol. 2023. PMID: 37666321.
156. Nishikawa R, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Yamamoto E, Ozasa N, Tada T, Sakamoto H, Seko Y, Shiba M, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. The characteristics and outcomes in patients with acute heart failure who used tolvaptan: from KCHF registry. ESC Heart Fail. 2023;10:3141-3151.
157. Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, Nishimoto Y, Sato Y, Takada T, Jujo K, Minami Y, Ogihara Y, Dohi K, Fujita M, Nishikawa T, Ikeda N, Hashimoto G, Otsui K, Mori K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Yoshikawa Y, Kimura T; ONCO DVT Study Investigators. Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial. Circulation. 2023;148:1665-1676.
158. Obayashi Y, et al. The Impact of Mitral Regurgitation on Long-Term Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Am J Cardiol 2023:203:384-393.
159. Nishimoto Y. Trends in Mechanical Circulatory Support Use and Outcomes of Patients With Cardiogenic Shock in Japan, 2010 to 2020 (from a Nationwide Inpatient Database Study). Am J Cardiol 2023:203:203-211.
160. Kaneda K, et al. Post-contrast Acute Kidney Injury After Emergent and Elective Percutaneous Coronary Intervention (from the CREDO-Kyoto PCI/CABG Registry Cohort 3). Am J Cardiol 2023:202:58-66.
161. Seko Y, et al. Weight loss during follow-up in patients with acute heart failure: From the KCHF registry. PLoS One 2023;18:e0287637.
162. Nishimoto Y, et. Trends in Treatment Patterns and Outcomes of Patients With Pulmonary Embolism in Japan, 2010 to 2020: A Nationwide Inpatient Database Study. J Am Heart Assoc 2023 Jun 20;12(12):e028981.
163. Hamatani Y, et al. Effectiveness and safety of morphine administration for refractory dyspnoea among hospitalised patients with advanced heart failure: the Morphine-HF study. BMJ Support Palliat Care 2023 May 11:spcare-2023-004247.
164. Shiba M, et al. Heterogeneity in Characteristics and Outcomes of Patients who met the Indications for Vericiguat Approved by the Japanese Agency: From the KCHF Registry. J Card Fail 2023 Jun;29(6):976-978.
165. Obayashi Y, et al. Tricuspid regurgitation in elderly patients with acute heart failure: insights from the KCHF registry. ESC Heart Fail 2023 Jun;10(3):1948-1960.
166. Seko Y, et al. Association between changes in loop diuretic dose and outcomes in acute heart failure. ESC Heart Fail 2023;10:1757-1770.
167. Yaku H, et al. Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial. Am Heart J 2023:260:18-25.
168. Nishimoto Y, et al. Effectiveness of systemic thrombolysis on clinical outcomes in high-risk pulmonary embolism patients with venoarterial extracorporeal membrane oxygenation: a nationwide inpatient database study. J Intensive Care 2023 Feb 6;11(1):4. doi: 10.1186/s40560-023-00651-w.
169. Aida K, et al. Prognostic Value of the Severity of Clinical Congestion in Patients Hospitalized for Decompensated Heart Failure: Findings From the Japanese KCHF Registry. J Card Fail 2023;29:1150-1162.
170. Miyamoto R, et al. Relationship between atrial fibrillation and a liver fibrogenesis marker in patients with acute heart failure. Int J Cardiol 2023:374:51-57.
171. Hamatani Y, et al. Association of intravenous heparin administration with in-hospital clinical outcomes among hospitalized patients with acute heart failure. Int J Cardiol 2023:370:229-235.
172. Takeji Y, et al. Sex Differences in Clinical Outcomes After Percutaneous Coronary Intervention. Circ J 2023;87:277-286.
173. Washida K, et al. A comparison between hospital follow-up and collaborative follow-up in patients with acute heart failure. ESC Heart Fail 2023;10:353-365.
174. Nakayama H, Toma M, Kobayashi T, Sato Y. Abdominal Aortic Aneurysm Shrinkage up to 2 Years Following Endovascular Repair with PEmbolization for Preventing Type 2 Endoleak: A Retrospective Single Center Study. Ann Vasc Surg 2023:88:308-317.
175. Nakayama H, Toma M, Kobayashi T, Hara R, Sato Y. Pre-constrain technique using the Gore Excluder Conformable endograft for abdominal aortic aneurysm with severely angulated proximal neck. J Vasc Surg Cases Innov Tech 2024;10:101614.
176. Nagao K, Kato T, Yaku H, Morimoto T, Aida K, Maruichi SK, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inada T, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Sato Y, Kuwahara K, Ozasa N, Ono K, Kimura T. Differential Prognostic Impact of Clinical Congestion between Preserved versus Reduced Ejection Fraction in Patients Hospitalized for Acute Decompensated Heart Failure: Findings from the Japanese Kyoto Congestive Heart Failure Registry. J Card Fail 2024:S1071-9164(24)00413-5.
177. Nishimoto Y, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Sato Y, Watanabe T, Yamada T, Fukunami M, Kimura T; COMMAND VTE Registry-2 Investigators. External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2. J Thromb Haemost 2024;22:2784-2796.
178. Kanenawa K, Yamaji K, Morimoto T, Yamamoto K, Domei T, Hyodo M, Shiomi H, Furukawa Y, Nakagawa Y, Kadota K, Watanabe H, Yoshikawa Y, Tada T, Tazaki J, Ehara N, Taniguchi R, Tamura T, Iwakura A, Tada T, Suwa S, Toyofuku M, Inada T, Kaneda K, Ogawa T, Takeda T, Sakai H, Yamamoto T, Tambara K, Esaki J, Eizawa H, Yamada M, Shinoda E, Nishizawa J, Mabuchi H, Tamura N, Shirotani M, Nakayama S, Uegaito T, Matsuda M, Takahashi M, Inoko M, Kanemitsu N, Tamura T, Ishii K, Nawada R, Onodera T, Ohno N, Koyama T, Tsuneyoshi H, Sakamoto H, Aoyama T, Miki S, Tanaka M, Sato Y, Yamazaki F, Hanyu M, Soga Y, Komiya T, Minatoya K, Ando K, Kimura T. Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registry. J Cardiol 2024;84:300-310.
179. Tanaka M, Kohjitani H, Yamamoto E, Morimoto T, Kato T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Shiba M, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Okuno Y, Kimura T, Ono K; KCHF Study Investigators. Development of interpretable machine learning models to predict in-hospital prognosis of acute heart failure patients. ESC Heart Fail 2024;11:2798-2812.
180. Yoshihara F, Matsuzawa Y, Nakatsuka K, Kirigaya J, Takeuchi I, Kimura K, Konishi M, Tamura K, Fukui K, Tsukahara K, Shimizu H, Iwabuchi K, Yamada Y, Saka K, Sato Y, Ogawa M, Hayakawa K, Ohmagari N, Ikeda S, Akao M, Shimomura H, Kihara Y, Yoshimoto A, Morita M, Kumada N, Ogata S, Nishimura K, Arisato T, Matsuo M, Kishida M, Yasuda S, Ogawa H. Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital. Hypertens Res 2024;47:1943-1951.
181. Nishimoto Y, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Sato Y, Watanabe T, Yamada T, Fukunami M, Kimura T; COMMAND VTE Registry-2 Investigators. Direct oral anticoagulant-associated bleeding complications in patients with gastrointestinal cancer and venous thromboembolism. Eur J Intern Med 2024;127:74-83.
182. Shimizu Y, Yoshitani K, Kuriyama T, Mori K, Kujira K, Imai M, Fukuhara R, Taniguchi R, Toma M, Miyamoto T, Sato Y. The effect of an initial catheter ablation with an adjunctive ethanol infusion into the vein of Marshall on persistent atrial fibrillation. J Cardiovasc Electrophysiol 2024;35:453-460.
183. Matsuda H, Kuragaichi T, Sato Y. Investigating the seasonal variation of heart failure hospitalizations and in-hospital mortality risks in Japan using a nationwide database. J Cardiol. 2024;83:236-242.
184. Hamatani Y, Iguchi M, Moriuchi K, Anchi Y, Inuzuka Y, Nishikawa R, Shimamura K, Kondo H, Mima H, Yamashita Y, Takabayashi K, Takenaka K, Korai K, Kawase Y, Murai R, Yaku H, Nagao K, Kitano M, Aono Y, Kitai T, Sato Y, Kimura T, Akao M. Effectiveness and safety of morphine administration for refractory dyspnoea among hospitalised patients with advanced heart failure: the Morphine-HF study. BMJ Support Palliat Care 2024;13(e3):e1300-e1307.

以上